Erythema multiforme due to clonazepam — supportive evidence from the macrophage migration inhibition factor test

doi:10.1046/j.1365-2230.1998.00358.x

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

Clinical and Experimental Dermatology

Volume 23 Issue 5, Pages 206 - 207

Published Online: 4 Jan 2002

An Official Journal of the British Association of Dermatologists

Go to Society Site

< Previous Abstract | Next Abstract >

Save Article to My Profile Download Citation Request Permissions

Abstract | References | Full Text: HTML, PDF (Size: 36K) | Related Articles | Citation Tracking

Erythema multiforme due to clonazepam — supportive evidence from the macrophage migration inhibition factor test

AMICHAI & GRUNWALD

⁰ Huzot Clinic of Kupat Holim, Ashkelon, Israel, ¹ Department of Dermatology, Soroka Medical Centre, Ben-Gurion University Negev, Beer-Sheva, Israel

Correspondence to: Dr Grunwald

ABSTRACT

Clonazepam is widely used in neurology, cutaneous side-effects being uncommon. We now describe a case of erythema multiforme induced by clonazepam. The diagnosis of drug-induced erythema multiforme is based on the clinical data and is supported by a positive macrophage migration inhibition factor test against the preparation.

DIGITAL OBJECT IDENTIFIER (DOI)

10.1046/j.1365-2230.1998.00358.x About DOI